US Capitol Capsule: Sex, drugs & equality: more than flibanserin
This article was originally published in Scrip
Executive Summary
With the vigorous debate that went on in a jam-packed room at the FDA's headquarters on 4 June between various members of the public over whether the agency should approve Sprout Pharmaceuticals' pill for boosting a woman's libido, one would think achieving equality in women's health revolved around sex dysfunction products alone.